• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For March 28, 2024

    3/28/24 5:24:44 AM ET
    $ACHV
    $ACNT
    $AFMD
    $AONC
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care
    Steel/Iron Ore
    Industrials
    Get the next $ACHV alert in real time by email

    Companies Reporting Before The Bell

    • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million.

    • Shimmick (NASDAQ:SHIM) is estimated to report quarterly loss at $0.20 per share on revenue of $158.50 million.

    • MSC Industrial Direct Co (NYSE:MSM) is estimated to report quarterly earnings at $1.16 per share on revenue of $946.55 million.

    • Walgreens Boots Alliance (NASDAQ:WBA) is likely to report quarterly earnings at $0.75 per share on revenue of $33.03 billion.

    • Data Storage (NASDAQ:DTST) is projected to report earnings for its fourth quarter.

    • Affimed (NASDAQ:AFMD) is likely to report quarterly loss at $1.68 per share on revenue of $1.71 million.

    • Atour Lifestyle Holdings (NASDAQ:ATAT) is expected to report quarterly earnings at $0.19 per share on revenue of $168.26 million.

    • CNFinance Hldgs (NYSE:CNF) is likely to report quarterly earnings at $0.01 per share on revenue of $65.41 million.

    • BRP (NASDAQ:DOOO) is estimated to report quarterly earnings at $1.92 per share on revenue of $2.05 billion.

    • OptimizeRx (NASDAQ:OPRX) is estimated to report quarterly earnings at $0.26 per share on revenue of $26.47 million.

    • Azul (NYSE:AZUL) is likely to report quarterly earnings at $0.14 per share on revenue of $985.30 million.

    • Imunon (NASDAQ:IMNN) is projected to report earnings for its fourth quarter.

    • Iterum Therapeutics (NASDAQ:ITRM) is expected to report earnings for its fourth quarter.

    • DarioHealth (NASDAQ:DRIO) is projected to report quarterly loss at $0.54 per share on revenue of $3.57 million.

    • Cheche Group (NASDAQ:CCG) is expected to report earnings for its fourth quarter.

    • Telesat (NASDAQ:TSAT) is projected to report earnings for its fourth quarter.

    • Jiayin Gr (NASDAQ:JFIN) is projected to report earnings for its fourth quarter.

    • IM Cannabis (NASDAQ:IMCC) is estimated to report quarterly loss at $0.17 per share on revenue of $10.45 million.

    • Smart Share Glb (NASDAQ:EM) is expected to report earnings for its fourth quarter.

    • 36KR Holdings (NASDAQ:KRKR) is projected to report earnings for its fourth quarter.

    • 22nd Century Group (NASDAQ:XXII) is estimated to report quarterly loss at $0.55 per share on revenue of $17.10 million.

    • China Automotive Systems (NASDAQ:CAAS) is estimated to report earnings for its fourth quarter.

    • REX American Resources (NYSE:REX) is expected to report quarterly earnings at $0.68 per share on revenue of $190.26 million.

    • D-Wave Quantum (NYSE:QBTS) is projected to report quarterly loss at $0.10 per share on revenue of $4.73 million.

    • Hut 8 (NASDAQ:HUT) is expected to report quarterly loss at $0.25 per share on revenue of $23.66 million.

    • American Oncology Network (NASDAQ:AONC) is estimated to report earnings for its fourth quarter.

    • Gold Royalty (AMEX:GROY) is estimated to report quarterly loss at $0.01 per share on revenue of $1.90 million.

    • Better Home & Finance (NASDAQ:BETR) is projected to report earnings for its fourth quarter.

    • BOS Better Online Solns (NASDAQ:BOSC) is projected to report earnings for its fourth quarter.

    Companies Reporting After The Bell

    • INmune Bio (NASDAQ:INMB) is estimated to report quarterly loss at $0.44 per share on revenue of $40 thousand.

    • Dolphin Entertainment (NASDAQ:DLPN) is likely to report quarterly earnings at $0.00 per share on revenue of $11.10 million.

    • Ascent Industries (NASDAQ:ACNT) is expected to report quarterly loss at $0.08 per share on revenue of $63.50 million.

    • Kodiak Sciences (NASDAQ:KOD) is expected to report earnings for its fourth quarter.

    • Pineapple Energy (NASDAQ:PEGY) is estimated to report quarterly earnings at $0.00 per share on revenue of $20.40 million.

    • Oxford Industries (NYSE:OXM) is projected to report quarterly earnings at $1.95 per share on revenue of $408.18 million.

    • Naas Technology (NASDAQ:NAAS) is estimated to report earnings for its fourth quarter.

    • Danimer Scientific (NYSE:DNMR) is projected to report quarterly loss at $0.38 per share on revenue of $11.33 million.

    • Dare Bioscience (NASDAQ:DARE) is expected to report quarterly loss at $0.10 per share on revenue of $1.79 million.

    • Intellinetics (AMEX:INLX) is estimated to report quarterly earnings at $0.04 per share on revenue of $4.10 million.

    • Shapeways Holdings (NASDAQ:SHPW) is expected to report quarterly loss at $0.95 per share on revenue of $9.25 million.

    • NRX Pharmaceuticals (NASDAQ:NRXP) is expected to report earnings for its fourth quarter.

    • CVD Equipment (NASDAQ:CVV) is projected to report earnings for its fourth quarter.

    • Nuvve Holding (NASDAQ:NVVE) is expected to report quarterly loss at $5.60 per share on revenue of $3.00 million.

    • NexGel (NASDAQ:NXGL) is projected to report quarterly loss at $0.11 per share on revenue of $1.38 million.

    • ENDRA Life Sciences (NASDAQ:NDRA) is expected to report earnings for its fourth quarter.

    • Zevra Therapeutics (NASDAQ:ZVRA) is estimated to report quarterly loss at $0.27 per share on revenue of $11.74 million.

    • American Res (NASDAQ:AREC) is projected to report quarterly loss at $0.04 per share on revenue of $2.20 million.

    • Vicinity Motor (NASDAQ:VEV) is estimated to report quarterly loss at $0.06 per share on revenue of $12.62 million.

    • Helius Medical Tech (NASDAQ:HSDT) is likely to report quarterly loss at $3.77 per share on revenue of $250 thousand.

    • Surf Air Mobility (NYSE:SRFM) is likely to report quarterly loss at $0.28 per share on revenue of $25.69 million.

    • Emeren Group (NYSE:SOL) is likely to report quarterly earnings at $0.00 per share on revenue of $44.98 million.

    • P3 Health Partners (NASDAQ:PIII) is expected to report quarterly loss at $0.11 per share on revenue of $302.97 million.

    • Energous (NASDAQ:WATT) is estimated to report quarterly loss at $0.85 per share on revenue of $200 thousand.

    • Dyadic International (NASDAQ:DYAI) is likely to report quarterly loss at $0.06 per share on revenue of $800 thousand.

    • Semtech (NASDAQ:SMTC) is projected to report quarterly loss at $0.03 per share on revenue of $196.46 million.

    • Torrid Holdings (NYSE:CURV) is likely to report quarterly loss at $0.08 per share on revenue of $274.83 million.

    • Pulse Biosciences (NASDAQ:PLSE) is likely to report earnings for its fourth quarter.

    • Arcadia Biosciences (NASDAQ:RKDA) is projected to report quarterly loss at $2.58 per share on revenue of $1.75 million.

    • Achieve Life Sciences (NASDAQ:ACHV) is projected to report earnings for its fourth quarter.

    • Sharecare (NASDAQ:SHCR) is expected to report quarterly loss at $0.06 per share on revenue of $114.99 million.

    • Expion360 (NASDAQ:XPON) is projected to report quarterly loss at $0.28 per share on revenue of $980 thousand.

    • Cepton (NASDAQ:CPTN) is expected to report quarterly loss at $0.74 per share on revenue of $2.46 million.

    • Vuzix (NASDAQ:VUZI) is estimated to report quarterly loss at $0.15 per share on revenue of $2.14 million.

    • Aspira Womens Health (NASDAQ:AWH) is estimated to report quarterly loss at $0.45 per share on revenue of $2.54 million.

    • Forian (NASDAQ:FORA) is estimated to report quarterly loss at $0.03 per share on revenue of $5.56 million.

    • Accelerate Diagnostics (NASDAQ:AXDX) is estimated to report quarterly loss at $0.62 per share on revenue of $3.45 million.

    • Wrap Technologies (NASDAQ:WRAP) is likely to report earnings for its fourth quarter.

    • Planet Labs (NYSE:PL) is projected to report quarterly loss at $0.06 per share on revenue of $58.19 million.

    • Leafly Holdings (NASDAQ:LFLY) is likely to report quarterly loss at $1.45 per share on revenue of $9.49 million.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ACHV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACHV
    $ACNT
    $AFMD
    $AONC

    CompanyDatePrice TargetRatingAnalyst
    MSC Industrial Direct Company Inc.
    $MSM
    2/6/2026$95.00Overweight → Neutral
    Analyst
    Hut 8 Corp.
    $HUT
    2/2/2026$80.00Buy
    H.C. Wainwright
    Pulse Biosciences Inc
    $PLSE
    1/30/2026$25.00Outperform
    Mizuho
    Gold Royalty Corp.
    $GROY
    1/22/2026Buy → Hold
    Canaccord Genuity
    Oxford Industries Inc.
    $OXM
    1/13/2026$35.00 → $40.00Market Perform
    Telsey Advisory Group
    Shimmick Corporation
    $SHIM
    1/5/2026$6.00Hold → Buy
    Craig Hallum
    Atour Lifestyle Holdings Limited
    $ATAT
    1/2/2026$49.00Outperform
    CLSA
    D-Wave Quantum Inc.
    $QBTS
    12/17/2025$35.00Outperform
    Wedbush
    More analyst ratings

    $ACHV
    $ACNT
    $AFMD
    $AONC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    MSC Industrial downgraded by Analyst with a new price target

    Analyst downgraded MSC Industrial from Overweight to Neutral and set a new price target of $95.00

    2/6/26 8:09:59 AM ET
    $MSM
    Industrial Machinery/Components
    Industrials

    H.C. Wainwright resumed coverage on Hut 8 Mining with a new price target

    H.C. Wainwright resumed coverage of Hut 8 Mining with a rating of Buy and set a new price target of $80.00

    2/2/26 6:51:37 AM ET
    $HUT
    Finance: Consumer Services
    Finance

    Mizuho initiated coverage on Pulse Biosciences with a new price target

    Mizuho initiated coverage of Pulse Biosciences with a rating of Outperform and set a new price target of $25.00

    1/30/26 6:44:12 AM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    $ACHV
    $ACNT
    $AFMD
    $AONC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Commercial Officer Danahy Kevin Patrick exercised 60,000 shares at a strike of $1.53 and sold $1,403,400 worth of shares (60,000 units at $23.39) (SEC Form 4)

    4 - PULSE BIOSCIENCES, INC. (0001625101) (Issuer)

    2/11/26 7:46:34 PM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    Chairman and CEO Piluso Charles M. was granted 160,600 shares, increasing direct ownership by 180% to 250,032 units (SEC Form 4)

    4 - Data Storage Corp (0001419951) (Issuer)

    2/11/26 4:58:42 PM ET
    $DTST
    EDP Services
    Technology

    Chief Executive Officer O'Dowd William Iv bought $4,920 worth of shares (3,000 units at $1.64), increasing direct ownership by 0.69% to 434,690 units (SEC Form 4)

    4 - Dolphin Entertainment, Inc. (0001282224) (Issuer)

    2/11/26 4:38:15 PM ET
    $DLPN
    Other Consumer Services
    Consumer Discretionary

    $ACHV
    $ACNT
    $AFMD
    $AONC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Planet to Present at February Investor Events

    Planet Labs PBC (NYSE:PL), a leading provider of daily data and insights about change on Earth, today announced that it will participate in the following investor events: Robert Cardillo, Chief Strategist and Chairman of the Board of Planet Federal, will participate in a keynote discussion at Barclays' 43rd Annual Industrial Select Conference on Wednesday, February 18th, 2026, at 12:10 p.m. Eastern Time. The discussion will be hosted by Matt Spence, Managing Director and Global Head of Venture Capital Banking at Barclays. Robert Cardillo, Chief Strategist and Chairman of the Board of Planet Federal, will participate in a fireside chat at Citi's 2026 Global Industrial Tech and Mobility

    2/11/26 4:30:00 PM ET
    $PL
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Telehealth Now Available for DARE to PLAY™ Sildenafil Cream: First Evidence-Based Topical Arousal Cream for Women

    Developed and evaluated specifically for women, DARE to PLAY™ Sildenafil Cream is a first-of-its-kind female arousal cream, a non-hormonal topical cream shown in clinical studies to increase genital blood flow in 10–15 minutes, and improve arousal sensations based on clinically-validated endpoints. Market introduction of DARE to PLAY™ is expected to mark a breakthrough in women's sexual health and represents important progress toward closing one of medicine's most persistent gender gaps. Prescriptions will be fulfilled in the coming months via a 503B Outsourcing Facility. SAN DIEGO, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a purpose-driven health biotech com

    2/11/26 8:00:00 AM ET
    $DARE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    NEXGEL Announces Financing of $1.797 Million Relating to an Acquisition Targeted to Close in the First Quarter of 2026, Subject to the Completion of Due Diligence

    LANGHORNE, Pa., Feb. 10, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced the financing of $1.797 million relating to a potential acquisition targeted for the first quarter of 2026. The potential acquisition is subject to the completion of due diligence by both NEXGEL and the investor. The funds will be returned to the investor should the transaction not be consummated. "After successfully closing and integrating several acquisitions over the last several years

    2/10/26 9:00:00 AM ET
    $NXGL
    Medical/Dental Instruments
    Health Care

    $ACHV
    $ACNT
    $AFMD
    $AONC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer O'Dowd William Iv bought $4,920 worth of shares (3,000 units at $1.64), increasing direct ownership by 0.69% to 434,690 units (SEC Form 4)

    4 - Dolphin Entertainment, Inc. (0001282224) (Issuer)

    2/11/26 4:38:15 PM ET
    $DLPN
    Other Consumer Services
    Consumer Discretionary

    Director Smith Gary B bought $313 worth of shares (20 units at $15.66) and sold $254 worth of shares (20 units at $12.69) (SEC Form 4)

    4 - Planet Labs PBC (0001836833) (Issuer)

    2/3/26 6:35:28 PM ET
    $PL
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Chief Executive Officer O'Dowd William Iv bought $4,872 worth of shares (2,900 units at $1.68), increasing direct ownership by 0.68% to 431,690 units (SEC Form 4)

    4 - Dolphin Entertainment, Inc. (0001282224) (Issuer)

    2/2/26 5:25:10 PM ET
    $DLPN
    Other Consumer Services
    Consumer Discretionary

    $ACHV
    $ACNT
    $AFMD
    $AONC
    SEC Filings

    View All

    SEC Form S-8 filed by Better Home & Finance Holding Company

    S-8 - Better Home & Finance Holding Co (0001835856) (Filer)

    2/11/26 5:15:22 PM ET
    $BETR
    Finance: Consumer Services
    Finance

    NexGel Inc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure

    8-K - NEXGEL, INC. (0001468929) (Filer)

    2/11/26 8:33:07 AM ET
    $NXGL
    Medical/Dental Instruments
    Health Care

    SEC Form SCHEDULE 13G filed by Wrap Technologies Inc.

    SCHEDULE 13G - WRAP TECHNOLOGIES, INC. (0001702924) (Subject)

    2/11/26 7:35:15 AM ET
    $WRAP
    Ordnance And Accessories
    Industrials

    $ACHV
    $ACNT
    $AFMD
    $AONC
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    September 12, 2023 - FDA Issues Warning Letters to Firms Marketing Unapproved Eye Products

    For Immediate Release: September 12, 2023 The U.S. Food and Drug Administration has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products in violation of federal law. These warning letters are part of the agency’s ongoing effort to protect Americans from potentially harmful ophthalmic products. Eye products addressed in the eight warning letters are illegal

    9/12/23 10:44:21 AM ET
    $WBA
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    December 23, 2021 - FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

    For Immediate Release: December 23, 2021 Today, the U.S. Food and Drug Administration authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second

    12/23/21 9:06:12 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    FDA Approval for XACIATO issued to DARE BIOSCIENCE INC

    Submission status for DARE BIOSCIENCE INC's drug XACIATO (ORIG-1) with active ingredient CLINDAMYCIN PHOSPHATE has changed to 'Approval' on 12/07/2021. Application Category: NDA, Application Number: 215650, Application Classification: Type 5 - New Formulation or New Manufacturer

    12/7/21 12:35:25 PM ET
    $DARE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACHV
    $ACNT
    $AFMD
    $AONC
    Leadership Updates

    Live Leadership Updates

    View All

    Deep Isolation Appoints Paula Whitten-Doolin as General Counsel

    BERKELEY, Calif., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Deep Isolation Nuclear, Inc. ("Deep Isolation" or the "Company"), a leading innovator in nuclear waste disposal technology, today announced the appointment of Paula Whitten-Doolin as the Company's General Counsel, effective immediately. Ms. Whitten-Doolin brings more than 15 years of experience in corporate and legal affairs to Deep Isolation, with deep expertise in the energy sector and advising publicly traded companies. Most recently, she served as General Counsel, Chief Administrative Officer and Chief Compliance Officer for Houston First Corporation, where she managed corporate governance, negotiated multimillion-dollar land deals,

    2/3/26 8:00:00 AM ET
    $VUZI
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Better Welcomes Loveen Advani as Chief Financial Officer

    Better Home & Finance Holding Company (NASDAQ:BETR, BETRW)) ("Better" or the "Company"), the leading AI-native home finance company and the first fintech to fund more than $110 billion in loan volume, welcomes Loveen Advani as Better's Chief Financial Officer, effective today. "Loveen is a seasoned strategic and operational finance leader with a strong track record of guiding companies through growth and transformation," said Vishal Garg, CEO and Founder of Better. "He has repeatedly demonstrated the ability to align strategy, capital allocation, and execution. His experience and leadership style will be instrumental as we execute our strategic priorities in our next chapter of anticipate

    2/2/26 8:00:00 AM ET
    $BETR
    Finance: Consumer Services
    Finance

    KNOREX Appoints Michael Sun as Chief Financial Officer

    Senior finance executive Michael Sun named CFO KNOREX Ltd. (NYSE:KNRX) ("KNOREX" or the "Company"), a leading provider of AI-driven programmatic online advertising products and solutions, today announced that its Board of Directors has appointed Ning (Michael) Sun as Chief Financial Officer ("CFO"), effective January 22, 2026. The appointment strengthens the Company's executive leadership team as KNOREX builds internal infrastructure to support its next phase of accelerated growth as a public company. "Michael brings deep capital markets and public-company experience that KNOREX needs at this stage of our development," said Dr. Justin Choo, CEO and Chairman of KNOREX. "As we gain commer

    1/23/26 8:30:00 AM ET
    $JFIN
    $KNRX
    $SFUN
    Finance: Consumer Services
    Finance
    Computer Software: Programming Data Processing
    Technology

    $ACHV
    $ACNT
    $AFMD
    $AONC
    Financials

    Live finance-specific insights

    View All

    BOS to Release 2025 Fourth Quarter and Year End Financial Results on March 31, 2026

    RISHON LE ZION, Israel, Feb. 09, 2026 (GLOBE NEWSWIRE) -- BOS Better Online Solutions Ltd. ("BOS" or the "Company") (NASDAQ:BOSC), an integrator of supply chain technologies for the aerospace, defense, industrial and retail sectors, announced today that it will release financial results for the fourth quarter and full year ended December 31, 2025 before the market opens on Tuesday, March 31, 2026. Additionally, BOS will host a video conference call on March 31, 2026 at 8:30 a.m. EDT. A question-and-answer session will follow management's presentation. To access the video conference meeting, please click on the following link: https://us06web.zoom.us/j/7481721806?pwd=pmXNiVvvvuicaar9aMkZ

    2/9/26 9:00:00 AM ET
    $BOSC
    Computer Communications Equipment
    Telecommunications

    OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ET

    WALTHAM, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, will hold a conference call on Thursday, March 5, 2026, at 4:30 p.m. Eastern Time to discuss its results for the fourth quarter period ended December 31, 2025. The financial results will be issued in a press release prior to the call. OptimizeRx management will host the call, followed by a question-and-answer period. Details for the conference call can be found below: Date: Thursday, March 5, 2026 Time: 4:30 p.m. Eastern Time (1:30 p.m. Pacific T

    2/5/26 8:00:00 AM ET
    $OPRX
    Real Estate

    Pulse Biosciences Schedules Fourth Quarter & Full Year 2025 Financial Results Conference Call for February 19, 2026

    Pulse Biosciences, Inc. (NASDAQ:PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced it will report business updates and financial results for the fourth quarter and full year 2025 after market close on Thursday, February 19, 2026. Company management will host a corresponding conference call beginning at 1:30pm PT / 4:30pm ET. Investors interested in listening to the conference call may do so by dialing 1-800-715-9871 from the U.S. or 1-646-307-1963 internationally and providing Conference ID 7647402. A live and recorded webcast of the event will be available on the Pulse Bioscie

    2/4/26 4:05:00 PM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    $ACHV
    $ACNT
    $AFMD
    $AONC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Better Home & Finance Holding Company

    SC 13D/A - Better Home & Finance Holding Co (0001835856) (Subject)

    12/17/24 8:40:06 PM ET
    $BETR
    Finance: Consumer Services
    Finance

    SEC Form SC 13G filed by DarioHealth Corp.

    SC 13G - DarioHealth Corp. (0001533998) (Subject)

    12/13/24 4:05:12 PM ET
    $DRIO
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Torrid Holdings Inc.

    SC 13G - Torrid Holdings Inc. (0001792781) (Subject)

    12/12/24 6:06:52 PM ET
    $CURV
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    $ACHV
    $ACNT
    $AFMD
    $AONC
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Breaking: Stock Acquired at INmune Bio Inc. on Jun 26

    Recently, on June 26, 2024, Director Juda Scott bought $36,350 worth of shares (5,000 units at $7.27) (SEC Form 4) in INmune Bio Inc. This insider purchase is significant as it indicates confidence from someone within the company towards its future growth prospects. It's interesting to note that this purchase by Juda Scott follows a series of transactions by other insiders in the company. For example, Moss David J bought $149,993 worth of shares (18,028 units at $8.32) on April 24, 2024, increasing direct ownership by 1% to 1,268,179 units. This demonstrates a consistent trend of insider buying within the organization. Looking back at previous transactions, on May 16, 2024, several key ins

    6/26/24 2:54:12 PM ET
    $INMB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care